Table 3.

The Chemodrugs Used and Outcomes in These Patients Were Compared.

	Age (years)	Tested drugs	Chemotherapy drugs	Clinical response	Observation time (m)
Carcinosarcoma, stage IV	68	Paclitaxel (10 nM), carboplatin (1 μM), gemcitabine (100 nM), doxorubicin (100 nM)	None	dead	18 days
112-24 HGSC-1, stage IIIC	48	Paclitaxel (10 nM), carboplatin (2 μM), gemcitabine (100 nM), doxorubicin (1 μM)	Paclitaxel (175 mg/m2), carboplatin (AUC = 5), adding Avastin and 7.5 mg/kg5 since the third course, will be continued for 22 course	NED	9 m
112-25 HGSC-2, stage IIIC	34	Paclitaxel (15 nM), carboplatin (20 μM), gemcitabine (800 nM), doxorubicin (8 μM)	Paclitaxel (135 mg/m2), carboplatin (AUC = 5)	NED	9 m

NED: no evidence of disease, m: month, AUC: area under curve.